Results 1 to 10 of about 3,917 (113)

Peripheral frataxin levels govern long-term clinical progression in Friedreich ataxia [PDF]

open access: yesBMJ Neurology Open
Background Novel therapeutics for Friedreich ataxia employ diverse strategies to increase frataxin protein levels, and a better understanding of the relation to clinical outcomes could strengthen their use as pharmacodynamic markers, and potentially as ...
Shana McCormack   +20 more
doaj   +2 more sources

Hypomagnetic Field Exposure Alters Iron–Sulfur Homeostasis and Oxidative Balance in a Frataxin-Deficient Insect System [PDF]

open access: yesInsects
Frataxin is a conserved mitochondrial protein essential for cellular iron–sulfur (Fe–S) cluster biogenesis and oxidative balance, with its deficiency causing Friedreich’s ataxia in humans.
Hui-Ming Kang   +6 more
doaj   +2 more sources

Pathological frataxin deficiency in mice causes tissue-specific alterations in iron homeostasis [PDF]

open access: yesiScience
Summary: Friedreich ataxia is caused by partial frataxin deficiency due to genetic mutations. It is well established that frataxin knockout affects iron homeostasis, but the alterations caused by pathological (partial) frataxin deficiency are poorly ...
Maria Pazos-Gil   +10 more
doaj   +2 more sources

E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia

open access: yesCell Reports, 2017
Friedreich ataxia (FRDA) is a severe genetic neurodegenerative disease caused by reduced expression of the mitochondrial protein frataxin. To date, there is no therapy to treat this condition.
Silvia Fortuni   +2 more
exaly   +3 more sources

Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells

open access: yesNeurobiology of Disease, 2015
Friedreich ataxia is an inherited neurodegenerative disease that leads to progressive disability. There is currently no effective treatment and patients die prematurely.
Alessandra Rufini   +2 more
exaly   +3 more sources

Hypomagnetic Fields Influence the Developmental Duration, Fecundity and Temperature Stress Resistance of Drosophila melanogaster via Frataxin-Associated Traits [PDF]

open access: yesBiology
Frataxin is a highly conserved mitochondrial protein that plays a key role in iron homeostasis and metabolism, and its deficiency leads to oxidative stress, mitochondrial dysfunction, and neurodegeneration.
Huiming Kang   +3 more
doaj   +2 more sources

Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich’s ataxia: insights from in vitro models [PDF]

open access: yesRedox Report
Friedreich’s Ataxia (FRDA) is a rare neurological disorder caused by an abnormal expansion of Guanine-Adenine-Adenine (GAA) repeat in intron 1 of the FXN gene, which encodes frataxin, leading to reduced expression of frataxin, a mitochondrial protein ...
Fred Jonathan Edzeamey   +6 more
doaj   +2 more sources

Protoporphyrin IX Binds to Iron(II)-Loaded and to Zinc-Loaded Human Frataxin

open access: yesLife, 2023
(1) Background: Human frataxin is an iron binding protein that participates in the biogenesis of iron sulfur clusters and enhances ferrochelatase activity.
Ganeko Bernardo-Seisdedos   +4 more
doaj   +1 more source

Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain

open access: yesCell Death and Disease, 2023
Friedreich ataxia (FRDA) is a rare, inherited neurodegenerative disease caused by an expanded GAA repeat in the first intron of the FXN gene, leading to transcriptional silencing and reduced expression of frataxin.
Davide Doni   +17 more
doaj   +1 more source

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia

open access: yesFrontiers in Neuroscience, 2022
Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by deficiency of the mitochondrial protein frataxin. Lack of frataxin causes neuronal loss in various areas of the CNS and PNS.
Elizabeth Mercado-Ayón   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy